Онкология
2394 статей · 70 журналов
Журналы подкатегории (70)
- Blood Neoplasia · Elsevier (100)
- Cancer Treatment and Research Communications · Elsevier (98)
- Brachytherapy · Elsevier (96)
- European Journal of Surgical Oncology · Elsevier (96)
- Cancer Epidemiology · Elsevier (95)
- The Lancet Oncology · Elsevier (95)
- International Journal of Gynecological Cancer · Elsevier (93)
- Biochimica et Biophysica Acta: Reviews on Cancer · Elsevier (89)
- EJC Skin Cancer · Elsevier (85)
- Journal of Thoracic Oncology · Elsevier (84)
- Lung Cancer · Elsevier (77)
- Asia-Pacific Journal of Clinical Oncology · Wiley (76)
- Urologic Oncology: Seminars and Original Investigations · Elsevier (73)
- Critical Reviews in Oncology/Hematology · Elsevier (70)
- Surgical Oncology Clinics of North America · Elsevier (66)
- European Journal of Cancer · Elsevier (65)
- Gynecologic Oncology Reports · Elsevier (65)
- Leukemia Research Reports · Elsevier (65)
- Bulletin du Cancer · Elsevier (59)
- Translational Oncology · Elsevier (59)
- Cancer Letters · Elsevier (57)
- Blood Reviews · Elsevier (54)
- Journal of the National Cancer Center · Elsevier (53)
- Leukemia Research · Elsevier (52)
- The Journal of Liquid Biopsy · Elsevier (52)
- Trends in Cancer · Elsevier (49)
- JACC: CardioOncology · Elsevier (46)
- Surgical Oncology Insight · Elsevier (43)
- Clinical Breast Cancer · Elsevier (40)
- ESMO Open · Elsevier (38)
- Cancer Pathogenesis and Therapy · Elsevier (37)
- Clinical Lung Cancer · Elsevier (33)
- Journal of Geriatric Oncology · Elsevier (30)
- Current Problems in Cancer: Case Reports · Elsevier (29)
- Journal of Bone Oncology · Elsevier (27)
- Precision Radiation Oncology · Wiley (25)
- Intelligent Oncology · Elsevier (19)
- Current Problems in Cancer · Elsevier (17)
- Immuno-Oncology and Technology · Elsevier (16)
- npj Precision Oncology · Springer Nature (12)
- Best Practice & Research Clinical Haematology · Elsevier (11)
- MedComm - Oncology · Wiley (10)
- European Journal of Cancer: Supplement · Elsevier (9)
- Nature Reviews Cancer · Springer Nature (9)
- Nature Reviews Clinical Oncology · Springer Nature (8)
- British Journal of Cancer · Springer Nature (7)
- Cancer Cytopathology · Wiley (5)
- BMC Cancer · Springer Nature (0)
- Breast Cancer Research · Springer Nature (0)
- Breast Cancer Research and Treatment · Springer Nature (0)
- Cancer Cell International · Springer Nature (0)
- Cancer Chemotherapy and Pharmacology · Springer Nature (0)
- Cancer and Metastasis Reviews · Springer Nature (0)
- Cardio-Oncology · Springer Nature (0)
- Cellular Oncology · Springer Nature (0)
- Clinical and Translational Oncology · Springer Nature (0)
- Current Breast Cancer Reports · Springer Nature (0)
- Current Hematologic Malignancy Reports · Springer Nature (0)
- Current Oncology Reports · Springer Nature (0)
- Immuno-Oncology · Springer Nature (0)
- Indian Journal of Gynecologic Oncology · Springer Nature (0)
- Indian Journal of Surgical Oncology · Springer Nature (0)
- Journal of Cancer Research and Clinical Oncology · Springer Nature (0)
- Journal of Gastrointestinal Cancer · Springer Nature (0)
- Journal of Mammary Gland Biology and Neoplasia · Springer Nature (0)
- Journal of the Egyptian National Cancer Institute · Springer Nature (0)
- Molecular Cancer · Springer Nature (0)
- Oncology and Therapy · Springer Nature (0)
- Strahlentherapie und Onkologie · Springer Nature (0)
- best practice onkologie · Springer Nature (0)
- A proliferation score defined by PCLI-anchored transcriptomics predicts outcomes in multiple myeloma
- Core competencies in brachytherapy training
- Refining risk in historically high-risk pediatric B-cell acute lymphoblastic leukemia: response kinetics and outcomes
- Brain brachytherapy treatment planning and delivery: A competency-based framework for contemporary multidisciplinary practice
- Endovascular brachytherapy using 125I seeds strand combined with transarterial chemoembolization, lenvatinib, and camrelizumab for unresectable hepatocellular carcinoma with hepatic vein tumor thrombus
- Gynecologic hybrid and interstitial high-dose-rate brachytherapy
- Clinical dosimetry for nose vestibule carcinoma interventional radiotherapy (modern brachytherapy): 15 year’s experience from a large tertiary center
- Travel time, insurance, and specialized cancer care for adolescents and young adults with acute lymphoblastic leukemia
- A long-term population-based study of lymphoplasmacytic lymphoma and Waldenström macroglobulinemia in Ontario, Canada
- Increased severe neurotoxicity and hospital stay in octogenarians receiving CAR T-cell therapy for large B-cell lymphoma
- Timing of response in patients with relapsed/refractory FLT3mut+ acute myeloid leukemia treated with gilteritinib
- Prognostic impact of age and MDS-associated mutations in NPM1-mutated AML
- CPX-351 plus gemtuzumab ozogamicin in relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndrome
- Pitavastatin counteracts venetoclax resistance mechanisms including TP53 mutation in acute myeloid leukemia
- Advances in differentiation syndrome in acute promyelocytic leukemia: From mechanisms to management
- Targeting the hepcidin–ferroportin axis in polycythemia vera: a complementary approach to clone-directed therapies
- Non-transfusion-dependent β-thalassemia: A disease of clinical paradoxes
- Reframing chronic myeloid leukemia outcomes beyond survival: a perspective of quality of life and patient-centered data
- Sequencing CD19-targeted therapies in patients with relapsed/refractory large B-cell lymphoma: A narrative review
- Beyond the platelet count: A systematic review of artificial intelligence in immune thrombocytopenia
- A comparison of overall survival and quality of life in patients with MDS treated with azacytidine vs decitabine
- Prognostic implications of TET2 variant allele frequency in chronic myelomonocytic leukemia: a multicenter study
- TCL1A polymorphism predicts AML progression in myeloid neoplasms
- Neonatal antiphospholipid syndrome–associated thrombosis: Diagnostic pitfalls and therapeutic frontiers
- Targeting tomorrow: Evaluation of novel agents for infants with KMT2A-rearranged acute lymphoblastic leukaemia
- The evolving landscape of tyrosine kinase inhibitors in chronic-phase chronic myeloid leukemia: A 25-year journey
- Transformed mycosis fungoides: Biological heterogeneity, clinicopathological features, and prognostic determinants
- Immune landscape and immunotherapeutic strategies for the treatment of TP53-mutated acute myeloid leukemia
- Artificial intelligence in myeloproliferative neoplasms: From digital bone marrow pathology to clinical decision support
- The blind spots of post-transplant AML relapse: from clinical signal to mechanism-matched therapy